Medlab Clinical Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	5.19	5.19	13.43
Cash & Cash Equivalents	5.19	5.19	13.43
Cash Growth	-	-61.36%	-
Receivables	0.08	0.08	0.06
Inventory	0.08	0.08	0.01
Other Current Assets	3.89	3.89	4.58
Total Current Assets	9.24	9.24	18.08
Property, Plant & Equipment	0.34	0.34	0.48
Goodwill and Intangibles	1.07	1.07	1.6
Other Long-Term Assets	0.71	0.71	0.48
Total Long-Term Assets	2.12	2.12	2.57
Total Assets	11.37	11.37	20.65
Accounts Payable	0.93	0.93	0.67
Current Debt	0.57	0.57	0.71
Other Current Liabilities	0.99	0.99	2.83
Total Current Liabilities	2.49	2.49	4.21
Long-Term Debt	0.55	0.55	0.99
Other Long-Term Liabilities	0.57	0.57	0.54
Total Long-Term Liabilities	1.12	1.12	1.53
Total Liabilities	3.62	3.62	5.74
Total Debt	1.12	1.12	1.7
Debt Growth	-	-33.76%	-
Retained Earnings	-59.53	-59.53	-52.37
Comprehensive Income	0.1	0.1	0.08
Shareholders' Equity	7.75	7.75	14.91
Net Cash / Debt	4.07	4.07	11.74
Net Cash / Debt Growth	-	-65.35%	-
Working Capital	6.75	6.75	13.87

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).